Jump to main content
Jump to site search

Issue 23, 2015
Previous Article Next Article

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Author affiliations

Abstract

Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

Graphical abstract: Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Back to tab navigation

Supplementary files

Article information


Submitted
07 Jan 2015
Accepted
05 Feb 2015
First published
18 Feb 2015

Chem. Commun., 2015,51, 4807-4810
Article type
Communication

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

H. Wang, M. Xu, M. Xiong and J. Cheng, Chem. Commun., 2015, 51, 4807
DOI: 10.1039/C5CC00148J

Social activity

Search articles by author

Spotlight

Advertisements